Cancer Diagnostics Market 2019, Trend, Geographical Segmentation, Forecast
The cancer diagnostics market is highly competitive with a large number of big and small players operating in different market segments.
Cancer Diagnostics Market(firmenpresse) - The Research Report on Cancer Diagnostics Market Consist 89 market data tables and 37 figures spread through 197 pages and in-depth TOC, which covers Global Market overview, Major Key Players detailed Analysis, market opportunities, market risk, forecast for the next five years, major driving factors for the market as well as detailed analysis for CAGR, scope, research findings, leading key players marketing strategy to acquire major market in the form of revenue.
Technological advancements in various fields such as biomarkers, imaging, biopsy, endoscopy; growing number of cancer cases, the rapid rise in geriatric population, awareness initiatives by governments, and increasing government funding are major factors driving the market growth.
The global cancer diagnostics market is segmented based on technology, application, and region.
Download PDF (cancer diagnostics):
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186559121
The platform-based technology is further segmented into next-generation sequencing, microarrays, PCR, flow cytometry, in situ hybridization, immunohistochemistry, and others. Instrument-based cancer diagnostics is further segmented into imaging systems and biopsy.
Cancer Diagnostics Market, by Application
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Others
Cancer Diagnostics Market, by Product
Next-generation Sequencing
Microarrays
PCR
Flow Cytometry
Instrument-based
Ultrasound
Mammography
Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=186559121
Based on region, the market is divided into North America, Europe, Asia, and Rest of the World (RoW). Rest of the World comprises Latin America, Pacific countries, and Middle East and Africa. North America is expected to account for the largest share in the cancer diagnostics market, followed by Europe and Asia. However, the Asian market is slated to grow at the highest CAGR in the coming five years and serves as a revenue pocket for the companies operating in the cancer diagnostics market.
Some of the major players in the global cancer diagnostics market include Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (Denmark), Becton, Dickinson and Company (U.S.), GE Healthcare (U.K.), QIAGEN N.V. (Netherlands), Abbott Laboratories, Inc. (U.S.), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Philips Healthcare (U.K.), and C.R. Bard, Inc. (U.S.).
Themen in dieser Pressemitteilung:
cancer-diagnostics
cancer-diagnostics-market
cancer-diagnostics-market-size
cancer-diagnostics-market-share
cancer-diagnostics-market-research
cancer-diagnostics-market-growth
cancer-diagnostics-industry
cancer-diagnostics-industry-analysis
Unternehmensinformation / Kurzprofil:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Datum: 22.05.2019 - 13:18 Uhr
Sprache: Deutsch
News-ID 592978
Anzahl Zeichen: 2837
contact information:
Contact person: shelly singh
Town:
northbrook
Phone: 18886006441
Kategorie:
Healthcare & Medical
Typ of Press Release: Financial
type of sending: send
Date of sending: 22.05.2019
Diese Pressemitteilung wurde bisher 166 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Cancer Diagnostics Market 2019, Trend, Geographical Segmentation, Forecast"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
